Suchergebnisse - "Chappell, James D"

PubPharm (6)

1

The coronavirus proofreading exoribonuclease mediates extensive viral recombination

enthalten in: PLoS pathogens | 2021

von Gribble, J. | Stevens, L. | Agostini, M. | +6

2

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

enthalten in: Science translational medicine | 2020

von Sheahan, T. | Sims, A. | Zhou, S. | +25

3

Small-Molecule Antiviral β-d-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance

enthalten in: Journal of virology | 2019

von Agostini, M. | Pruijssers, A. | Chappell, J. | +13

4

Improving Influenza Testing and Treatment in Hospitalized Children

enthalten in: Hospital pediatrics | 2018

von Murphy, A. | Lindegren, M. | Schaffner, W. | +8

5

Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy

enthalten in: The Journal of infectious diseases | 2017

von Achten, N. | Wu, P. | Bont, L. | +11

6

Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2010

von Dulek, D. | Williams, J. | Creech, C. | +5

1
[1]